Combined expertise and experience creates fully integrated, research to release, ophthalmic development services company. July 9, 2018 – Rush, New York and Tampa, Florida – iuvo BioScience, an industry leading R&D services company specializing in safety, microbiology, toxicology, and analytical chemistry testing for the medical device and pharmaceutical industries, announced today that it has added […]
June 29, 2018 – RUSH, NY – iuvo BioScience is proud to announce that, in a span of two weeks, the company hosted and passed re-accreditation inspections from the following agencies and for the following standards: US Department of Agriculture Annual Inspection ISO 17025:2017 reaccreditation audit ISO 13485:2016 surveillance audit AAALAC accreditation audit Debbie Sorochty, […]
June 12, 2018 – As iuvo recently wrapped up its 2018 United Way Campaign, iuvo’s Chief Scientific Officer Mary Richardson received a Shining Star award from the United Way of Greater Rochester in recognition for her commitment and leadership to this program. The Shining Star award recognizes consistent high performing senior champions and coordinators who […]
April 16, 2018 – iuvo BioScience’s Chief Scientific Officer Dr. Mary Richardson will be presenting on ophthalmic drug products considerations for E&L studies at the Product Quality Research Institute Extractables and Leachables Workshop this week. The PQRI PODP Extractables and Leachables Workshop takes place April 18-19, 2018 at the USP Meeting Center in Rockville, Maryland. […]
April 9, 2018 – Iuvo BioScience will be attending the Ophthalmology Innovation Summit (OIS) on April 12, 2018 at The Renaissance Washington, in Washington, DC. Ben Burton, iuvo’s CEO, will be in attendance. The OIS was designed to unite industry, entrepreneurs and clinical thought leaders to collaborate on the development and commercialization of innovative drugs […]
March 2, 2018 – iuvo BioScience will be attending the 57th Annual Meeting and ToxExpo for the Society of Toxicology, March 11-15, 2018. The meeting will be held at the Henry B. Gonzalez Convention Center in San Antonio, Texas. iuvo will be represented by Dr. Kathleen Krenzer and John Lanzafame. Please stop by our booth […]
NOVEMBER 15, 2017 – Dr. Kathleen Krenzer, iuvo BioScience’s Research Fellow in Toxicology, was recently chosen as the Vice President-Elect of the Ocular Toxicity Specialty Section of the Society of Toxicology. The position is elected annually by a vote of the membership of the SOT, and shall become the Vice President of the Specialty Section […]
November 8, 2017 – iuvo BioScience is proud to announce that our Chief Scientific Officer, Dr. Mary Richardson, was named a finalist for the 2018 ATHENA Awards. The ATHENA Awards are presented by the Greater Rochester Chamber of Commerce and is awarded annually to a professional female leader who has demonstrated achievements in business, community […]
NOVEMBER 5, 2017 – iuvo BioScience announced today that iuvo’s President and CEO Ben Burton was named to the Board of Directors of MedTech at the MedTech 2017 Annual Meeting. Mr. Burton was excited about the opportunity to serve MedTech. “We’ve been a member of MedTech since the summer of 2015, right after we established […]
November 1, 2017 – iuvo BioScience announced today that the company will be attending the 38th Annual Meeting of the American College of Toxicology next week, November 5-8, 2017. The meeting will be held at the Palm Springs Convention Center in Palm Springs, California. Please stop by our booth in the exhibit hall if you […]
